Stock Information
Fennec Pharmaceuticals Inc (FENC)
Ticker Symbol: FENC
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $329.93 mil
Piotroski score: 5
PE Ratio: N/A
EPS (TTM): -0.2847
Revenue (TTM): $1.16 M
Dividend Yield: N/A%
ROE: -12.54%
Latest News
-
B. Riley Securities Reiterates Buy on Fennec Pharmaceuticals, Raises Price Target to $18
Wed, Aug 12, 2026 12:50 PM
-
Wedbush Maintains Outperform on Fennec Pharmaceuticals, Raises Price Target to $16
Wed, Aug 12, 2026 12:04 PM
-
Fennec: The Turnaround Is Real, But The Stock Prices In Perfection (Downgrade)
Wed, Aug 12, 2026 10:05 AM
-
Fennec Pharmaceuticals Inc. (FENC) Q2 2026 Earnings Call Transcript
Tue, Aug 11, 2026 12:57 PM
-
Fennec Pharmaceuticals Q2 EPS $0.05 Beats $0.02 Estimate, Sales $17.874M Beat $16.095M Estimate
Tue, Aug 11, 2026 7:03 AM
Key Financials
Financial data not available
